P53, MDR1 and SPF prognostic relevance in breast cancer

被引：0
|
作者：
Vielh, P [1 ]
Pouillart, P [1 ]
Klijanienko, J [1 ]
Fourquet, A [1 ]
Chevillard, S [1 ]
机构：
[1] Inst Curie, Paris, France
来源：
LABORATORY INVESTIGATION | 1998年 / 78卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
152
引用
下载
收藏
页码：29A / 29A
页数：1
相关论文
共 50 条
  • [21] Race and the Prognostic Influence of p53 in Women with Breast Cancer
    Dookeran, Keith A.
    Dignam, James J.
    Holloway, Nathaniel
    Ferrer, Karen
    Sekosan, Marin
    McCaskill-Stevens, Worta
    Gehlert, Sarah
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (07) : 2334 - 2344
  • [22] p53 expression as a prognostic marker in inflammatory breast cancer
    Gonzalez-Angulo, AM
    Sneige, N
    Buzdar, AU
    Valero, V
    Kau, SW
    Broglio, K
    Yamamura, Y
    Hortobagyi, GN
    Cristofanilli, M
    CLINICAL CANCER RESEARCH, 2004, 10 (18) : 6215 - 6221
  • [23] p53 oncoprotein as a prognostic indicator in patients with breast cancer
    Molina, R
    Segui, MA
    Climent, MA
    Bellmunt, J
    Albanelli, J
    Fernandez, M
    Filella, X
    Jo, J
    Gimenez, N
    Iglesias, E
    Miralles, M
    Alonso, C
    Peiro, G
    Perez-Picañol, E
    Ballesta, AM
    ANTICANCER RESEARCH, 1998, 18 (1B) : 507 - 511
  • [24] PROGNOSTIC VALUE OF P53 PROTEIN EXPRESSION IN BREAST CANCER
    Ben Slama, S.
    Bacha, D.
    Ben Amor, A.
    Halouani, A.
    Lahmar, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A33 - A33
  • [25] Prognostic significance of mutant p53 in breast cancer patients
    Castiglione, F
    Sarotto, I
    Destefanis, M
    Ricco, MT
    Porcile, G
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S24 - S24
  • [26] The inactivation of p53 can lead to the hyperexpression of the MDR1 gene and to chemoresistance in certain cancers
    Benard, J
    BULLETIN DU CANCER, 1997, 84 (11) : 1085 - 1085
  • [27] Targeting the miR-34a/LRPPRC/MDR1 axis collapse the chemoresistance in P53 inactive colorectal cancer
    Yang, Yang
    Yuan, Hongyu
    Zhao, Lianmei
    Guo, Shichao
    Hu, Sijun
    Tian, Miaomiao
    Nie, Yongzhan
    Yu, Jiarui
    Zhou, Chaoxi
    Niu, Jian
    Wang, Guiying
    Song, Yongmei
    CELL DEATH AND DIFFERENTIATION, 2022, 29 (11): : 2177 - 2189
  • [28] The clinical relevance of p53 isoforms modifying the effects of p53 mutation on survival from breast cancer
    Thompson, A.
    Patten, N.
    Diot, A.
    Truong, S. C.
    Bray, S.
    Ashfield, A.
    Baker, L.
    Quinlan, P.
    Wu, L.
    Bourdon, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] Targeting the miR-34a/LRPPRC/MDR1 axis collapse the chemoresistance in P53 inactive colorectal cancer
    Yang Yang
    Hongyu Yuan
    Lianmei Zhao
    Shichao Guo
    Sijun Hu
    Miaomiao Tian
    Yongzhan Nie
    Jiarui Yu
    Chaoxi Zhou
    Jian Niu
    Guiying Wang
    Yongmei Song
    Cell Death & Differentiation, 2022, 29 : 2177 - 2189
  • [30] TRANSACTIVATION OF THE HUMAN MULTIDRUG-RESISTANCE (MDR1) GENE PROMOTER BY P53 MUTANTS
    NGUYEN, KT
    LIU, BR
    UEDA, K
    GOTTESMAN, MM
    PASTAN, I
    CHIN, KV
    ONCOLOGY RESEARCH, 1994, 6 (02) : 71 - 77
12345